| abstract |
The present disclosure relates to living biotherapeutic products, probiotics, pharmaceutical compositions comprising such probiotics, and methods of their use to treat various human diseases. In some embodiments, the present disclosure provides such compositions comprising strains of bacterial Streptococcus aure Stralis and their use in the treatment of metabolic-related diseases or disorders. |